Weekly Investment Analysts’ Ratings Updates for Premier (PINC)

Premier (NASDAQ: PINC) recently received a number of ratings updates from brokerages and research firms:

• 8/25/2025 – Premier had its price target raised by analysts at Piper Sandler from $24.00 to $28.00. They now have a “neutral” rating on the stock.
• 8/20/2025 – Premier had its price target raised by analysts at UBS Group AG from $23.00 to $26.00. They now have a “neutral” rating on the stock.
• 8/20/2025 – Premier had its price target raised by analysts at Robert W. Baird from $22.00 to $27.00. They now have a “neutral” rating on the stock.
• 8/20/2025 – Premier had its price target raised by analysts at Canaccord Genuity Group Inc. from $22.00 to $25.00. They now have a “hold” rating on the stock.
• 8/19/2025 – Premier had its price target raised by analysts at Bank of America Corporation from $19.00 to $21.00. They now have an “underperform” rating on the stock.
• 8/19/2025 – Premier had its price target raised by analysts at Leerink Partners from $24.00 to $26.00. They now have a “market perform” rating on the stock.

Premier Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Monday, September 1st will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Friday, August 29th. Premier’s payout ratio is 381.82%.

Insider Transactions at Premier

In other Premier news, General Counsel David L. Klatsky sold 1,319 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $25.85, for a total transaction of $34,096.15. Following the completion of the transaction, the general counsel owned 94,331 shares of the company’s stock, valued at $2,438,456.35. This represents a 1.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director John T. Bigalke sold 1,137 shares of the company’s stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $23.03, for a total value of $26,185.11. Following the transaction, the director owned 28,673 shares in the company, valued at $660,339.19. This trade represents a 3.81% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 5,805 shares of company stock valued at $145,915. 0.96% of the stock is currently owned by corporate insiders.

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.